Importer of Controlled Substances; Notice of Registration; Siegfried USA, LLC, 14296 [2014-05497]

Download as PDF 14296 Federal Register / Vol. 79, No. 49 / Thursday, March 13, 2014 / Notices DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration; GE Healthcare Importer of Controlled Substances; Notice of Registration; Siegfried USA, LLC Importer of Controlled Substances; Notice of Registration; Johnson Matthey, Inc. By Notice dated December 23, 2013, and published in the Federal Register on January 10, 2014, 79 FR 1887, Siegfried USA, LLC., 33 Industrial Park Road, Pennsville, New Jersey 08070, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances: By Notice dated November 4, 2013, and published in the Federal Register on November 18, 2013, 78 FR 69130, Johnson Matthey, Inc., Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, New Jersey 08066–1742, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances: By Notice dated November 2, 2013, and published in the Federal Register on November 19, 2013, 78 FR 69447, GE Healthcare, 3350 North Ridge Avenue, Arlington Heights, Illinois 60004–1412, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Cocaine (9041), a basic class of controlled substance listed in schedule II. The company plans to import small quantities of ioflupane, in the form of three separate analogues of Cocaine, that will be used for the support and manufacture of DaTSCAN (ioflupane I– 123) injections for distribution as a radioactive diagnostic imaging agent utilized in the diagnosis of Parkinson’s disease. No comments or objections have been received. The DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of GE Healthcare to import the basic class of controlled substance is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA has investigated GE Healthcare to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. TKELLEY on DSK3SPTVN1PROD with NOTICES Dated: February 19, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2014–05480 Filed 3–12–14; 8:45 am] BILLING CODE 4410–09–P Drug Schedule Opium, raw (9600) ....................... Poppy Straw Concentrate (9670) II II The company plans to import the listed controlled substances to bulk manufacture APIs for distribution to its customer. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (January 25, 2007). The DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Siegfried USA, LLC., to import the basic classes of controlled substances is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA has investigated Siegfried USA, LLC., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: February 19, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2014–05497 Filed 3–12–14; 8:45 am] BILLING CODE 4410–09–P VerDate Mar<15>2010 17:33 Mar 12, 2014 Jkt 232001 PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 Drug Coca Leaves (9040) ..................... Thebaine (9333) ........................... Opium, raw (9600) ....................... Noroxymorphone (9668) .............. Poppy Straw Concentrate (9670) Schedule II II II II II The company plans to import the listed controlled substances as raw materials, to be used in the manufacture of bulk controlled substances, for distribution to its customers. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417, (January 25, 2007). In reference to the non-narcotic raw material, no comments or objections have been received. The company plans to import gram amounts to be used as reference standards for distribution to its customers. The DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Johnson Matthey, Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA has investigated Johnson Matthey, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. E:\FR\FM\13MRN1.SGM 13MRN1

Agencies

[Federal Register Volume 79, Number 49 (Thursday, March 13, 2014)]
[Notices]
[Page 14296]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-05497]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; 
Siegfried USA, LLC

    By Notice dated December 23, 2013, and published in the Federal 
Register on January 10, 2014, 79 FR 1887, Siegfried USA, LLC., 33 
Industrial Park Road, Pennsville, New Jersey 08070, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as an importer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Opium, raw (9600)..........................  II
Poppy Straw Concentrate (9670).............  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances to 
bulk manufacture APIs for distribution to its customer.
    Comments and requests for hearings on applications to import 
narcotic raw material are not appropriate. 72 FR 3417 (January 25, 
2007).
    The DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), 
and determined that the registration of Siegfried USA, LLC., to import 
the basic classes of controlled substances is consistent with the 
public interest, and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971. The DEA 
has investigated Siegfried USA, LLC., to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic classes of controlled 
substances listed.

    Dated: February 19, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2014-05497 Filed 3-12-14; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.